A clinically and functionally relevant definition of an asthma exacerbation will be invaluable in the assessment of the severity of such an event and the streamlining of the steps necessary to ...
Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...
GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...
Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.
GSK plc has announced that new drug applications have been accepted for review by the China National Medical Products ...
Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...
Environmental and Socioeconomic Factors Fuel Respiratory Health Disparities in Rural and Urban Areas
Research highlights how poor housing, pollution, and green spaces affect respiratory health, with rural and urban communities ...
San Diego is fighting two battles--- wildfires and air quality. Experts warn of exposure to smoke following Border 2 fire.
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...
Dr. Neha Reshamwala, owner of Frontier Allergy, Asthma & Immunology, with BioBehavioral Research of Austin (BBRA) stopped by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback